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Carotid atherosclerosis lipid profiling by MALDI-MSI
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Abstract. Atherosclerosis is a lipid and
inflammation-driven disease of the arteries that
is characterized by gradual buildup of plaques in
the vascular wall. A so-called vulnerable plaque,
consisting of a lipid-rich necrotic core contained
by a thin fibrous cap, may rupture and trigger
thrombus formation, which can lead to ischemia
in the heart (heart attack) or in the brain (stroke).
In this study, we present a protocol to investigate
the lipid composition of advanced human carotid
plaques usingmatrix-assisted laser desorption ionization (MALDI) mass spectrometry imaging (MSI), providing a
framework that should enable the discrimination of vulnerable from stable plaques based on lipid composition.
We optimized the tissue preparation and imaging methods by systematically analyzing data from three speci-
mens: two human carotid endarterectomy samples (advanced plaque) and one autopsy sample (early stage
plaque). We show a robust data reduction method and evaluate the variability of the endarterectomy samples.
We found diacylglycerols to be more abundant in a thrombotic area compared to other plaque areas and could
distinguish advanced plaque from early stage plaque based on cholesteryl ester composition.We plan to use this
systematic approach to analyze a larger dataset of carotid atherosclerotic plaques.
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Introduction
Atherosclerosis is the cause of more than 10 million deathsworldwide, and a major contributor to long-term morbid-
ity and disability [1]. This disease of the artery walls is char-
acterized by the gradual formation of depositions in the vascu-
lar wall that are called atherosclerotic plaques. Plaque growth is
initiated by endothelial dysfunction and driven by impaired
lipid transport mechanisms, which trigger an inflammatory
response. Lipids thus play a key role in the pathogenesis of
atherosclerosis. Besides a variety of lipid species, these plaques
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contain calcifications, fibrous tissue, smooth muscle cells, and
necrotic material [2, 3]. Depending on the tissue composition
and structure of the plaque, plaques can be either “stable” or
”vulnerable,” the latter means they are prone to rupture. Plaque
rupture may trigger embolization of fragments of plaque tissue
in the bloodstream, which, depending on the anatomical loca-
tion of the plaque, can lead to stroke or myocardial infarction
[3, 4]. The mechanisms driving the evolution of a stable plaque
to a vulnerable phenotype are not known in detail, although it is
clear that defective or unbalanced lipid transport plays a key
role [5–9]. The recent LRP study (presented at TCT2018 [10])
demonstrated that coronary vessel segments with lipid-rich
plaque have a > 4 times higher clinical event rate than vessel
segments without such plaque, highlighting the importance of
plaque lipid content for triggering ischemia. We aim to study
whether the lipid profile differs between stable and vulnerable
plaque types. To determine whether a plaque’s lipid profile can
be correlated to plaque phenotype and, therefore, risk of rup-
ture, variation between and within plaque samples needs to be
assessed. In this study, we present a mass spectrometry imag-
ing (MSI) method for systematically studying plaque lipid
distribution at various stages of development. MSI is an emerg-
ing experimental technique in the molecular characterization of
biological samples. Using MSI, the molecular composition of
thin tissue sections can be imaged at a micron-scale resolution.
As an initial step, MSI requires ionization of the tissue section.
Different methods of ionization exist, including matrix-assisted
laser desorption ionization (MALDI), a commonly used ioni-
zation method for biological samples [11]. The main advan-
tages of MALDI are its ability to generate singly charged ions,
which greatly simplifies analysis of mass spectra, and its ability
of so-called soft ionization, preventing molecules from
fragmenting during the ionization process [11]. MALDI-MSI
is suitable for the detection of small molecules, such as lipids.
To date, few studies of (MALDI-)MSI on human arteries
have been published [12–18]. They explored the parameter
space of atherosclerotic plaque composition as sampled by
MSI along various dimensions. Prior work examined different
arterial beds, i.e., aorta [16], carotid [14, 15, 17], coronary
arteries [13], femoral, or popliteal [12, 18], and differed in the
ionization method used, i.e., MALDI [12, 16–18], secondary
ion mass spectrometry (SIMS) [13, 14] or desorption
electrospray ionization (DESI) [15]. Clinically relevant
plaques, those that are likely to precipitate ischemic events,
contain a variable mix of lipids [6]. In studying the role of
various lipids [7, 19] in the atherosclerotic disease process, it is
therefore important to optimize the analysis for accurately
sampling the lipid spectrum, and to quantitatively understand
the variance in measured ion abundances. We consequently
chose to focus on lipid-rich plaques only, and moreover re-
stricted ourselves to carotid plaques, as these are a major
precursor of ischemic stroke [20].
Our aim is to develop a MALDI-MSI pipeline for the
analysis of lipids in human carotid artery plaques, suitable for
assessing the variation in lipid profile, both between different
plaque specimens and within different locations in the same
specimen. To that aim, we add the following insights to the
existing MSI knowledge: (1) We describe how arterial tissue
should be processed, such that the combination of MALDI-
MSI and histological information enables contextualization of
MSI data in terms of the known morphological features of
plaque pathology. (2) We combine various MSI data analysis
methods into a robust data processing pipeline that reliably
reduces an MSI dataset into manageable lipid-specific results.
We describe this pipeline in detail to encourage other re-
searchers to follow similar pipelines in their own research. (3)
We assess the reproducibility of measurements by calculating
the coefficient of variation of MALDI-MSI measurement re-
sults of tissue sections that were located close together.
In addition, we discuss tentative observations in three hu-
man carotid plaques that illustrate the potential for imaging
lipid biochemistry in atherosclerosis. This method is readily
applicable to larger collections, limited by scan time, of carotid
plaque specimens, allowing to assess the relation between the
carotid plaque’s molecular lipid composition and plaque type
using statistical methods.
Materials and Experimental Methods
Materials
DPBS (without calcium and magnesium), KP Haematoxyline
mayer (VWRK4085–9002), Resorcin (1075930100), and
SuperFrostPlus glass slides (76 × 26mm) were purchased from
VWR (The Netherlands). Eosine (HT110232-1 L), Oil Red O
(00625-25G), Basic Fuchsin (857343-25G), Ferric(III) chlo-
ride (157740-100G), 2,5-dihydroxybenzoic acid (98%,
149,357-100G) and porcine type A gelatin were purchased
from Sigma-Aldrich (The Netherlands). HPLC-grade acetone
was purchased from Fisher Scientific (The Netherlands).
Mouse anti-human CD31 (JC/70A, ab9498) and mouse anti-
human CD68 (KP1, ab955) were purchased from Abcam
(UK). EnVision + Kit (HRP, mouse, 1100 tests, 110 ml,
K4001) was purchased from Agilent (the Netherlands). Lipid
standards Cholest-5-en-3ß-yl heptadecanoate (CE 17:0) 1 mg/
mL (700,186 M−1 mg) and 1,2-diheptadecanoyl-sn-glycero-3-
phosphocholine (PC 17:0) 10 mg/mL (850360C-25 mg) were
purchased from Avanti Polar Lipids (USA).
Tissue Collection
Carotid endarterectomy (CEA) surgery was performed by care-
fully opening the outer wall of the carotid artery and excising
the plaque by separating the intima and media. This protocol
preserves an intact lumen and plaque morphology [21]. Two
human carotid plaque specimens, harvested at carotid endar-
terectomy (CEA) surgery, were rinsed in phosphate-buffered
saline (DPBS), snap frozen and stored at − 80 °C until further
processing. A third carotid artery specimen, without apparent
atherosclerotic disease, was collected at autopsy within 24 h
postmortem, from a subject with a non-cardiovascular cause of
death. This specimen was rinsed in DPBS and stored in the
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same manner. Tissue collection was performed according to
protocols sanctioned by the Ethics Board at Erasmus MC
(MEC 2008-147 for carotid endarterectomy samples, MEC
2017-300 for the autopsy sample).
Sample Preparation
One CEA specimen, referred to as P1, was transversally divid-
ed into 1-mm segments to study intraplaque variability. We
hypothesize that the plaque’s molecular lipid composition may
change along the length of the vessel. Five 1-mm segments,
originating ≈ 3 mm apart, evenly spaced along the axial length
of the CEA sample, were used for imaging. Three of the
segments were located caudal to the carotid bifurcation and
two segments originated from the internal carotid artery, see
Figure 1. The second CEA specimen, referred to as P2, and the
autopsy specimen, referred to as A, were imaged in a single
axial location. The imaged 1 mm segment of P2 was located
cranial to the bifurcation, in the internal carotid artery, where
atherosclerotic disease stage is generally maximal. The imaged
1mm segment of A originated from the common carotid artery,
where no or minimal plaque formation is expected.
All 1 mm segments were embedded in 10% porcine type A
gelatin and cryosectioned (CM3050 S, Leica Biosystems (cut-
ting temps: OT − 21 °C; CT − 19 °C)), into 10 μm sections
which were then thaw mounted onto non-conductive glass
slides. After sectioning, the slides were stored at − 80 °C until
imaging or histological staining. Per segment, six sections were
imaged; the distance between MALDI-MSI sections was 30–
50 μm. All sections were imaged or stained within 2 months
after sectioning.
Prior to imaging, the slides were desiccated under vacuum at
room tempera ture for 10 min. The matr ix , 2 ,5-
dihydroxybenzoic acid (DHB), was applied using sublimation
(home-built sublimation system as described in Dekker et al.
[22]) at 125 °C for 10 min; 50 mg of DHB was dissolved in
5 ml acetone. No washing, re-crystallization, or addition of
ionization agents was used.
Histological Staining
Histological staining was performed on adjacent slides, which
were histochemically stained by Hematoxylin-Eosin (HE), Oil
Red O (ORO), and Resorcin-Fuchsin (RF) staining, to
visualize general structure, lipids, and collagen and elastin,
respectively. Immunohistochemical (IHC) staining was per-
formed to visualize endothelial cells and macrophages. The
slides imaged with MALDI-MSI were stained by ORO after
MSI.
We assessed the plaque tissue according to the plaque
classification scheme of Virmani et al. [2, 3] and examined
the tissue for features of plaque vulnerability (i.e., necrotic
core, calcification, thrombus). We also assessed the tissue’s
structural variability over consecutive tissue sections that
originate from the same 1 mm segment. We used the
histopathological data as a guidance to interpret the
MALDI-MSI data.
Data Acquisition
MALDI-MSI was performed on a MALDI-q-TOF mass spec-
trometer (Waters Synapt G2Si-TOF, Manchester, UK), operat-
ed in positive mode, at the instrument’s “resolution mode”
(single-pass reflectron TOF) with a spatial resolution of
50 μm. An Nd:YAG (355 nm) laser was operated at
2000 Hz, at 50% of the maximum laser energy available
(250/500 laser energy). At this energy level, the laser spot
was ≈ 40 μm in size. The mass range was 300–1200 m/z and
the scan time per pixel was 0.5 s using a left-right scanning
pattern. The data was acquired using MassLynx v4.1 software
(Waters, Manchester, UK), and HDimaging v1.4 software was
used to export the data to imzML format. Prior to imaging, the
machine was calibrated with red phosphorus spotted onto a
steel plate.
Mass Identification
For the identification of the various lipid components, lipids
were extracted [23] by homogenizing 5 mg of tissue in 250 μL
of Milli-Q water. The tissue was taken between sections P1–4
and P1–5. Ten microliters homogenized sample was combined
with 10 μL 10% TEA solution (trimethylamine (10/90, v/v) in
methanol/dichloromethane (DCM) (50/50, v/v)) and mixed
thoroughly. Subsequently, 450 μL methanol/DCM (50/50,
v/v) was added to this mixture. Samples were incubated on
the roller bank for 30 min at 4 °C. After incubation, samples
were centrifuged at 14,000 rpm for 20 min at 4 °C. Supernatant
was transferred to a glass vial, and freeze dried until further use.
Carotid endarterectomy 
5 locations
P1
Carotid endarterectomy
1 location
P2
Autopsy carotid
1 location
A
For every segment
6 - MSI (ORO) 
3 - IHC CD 68
3 - IHC CD 31
3 - RF
3 - ORO
3 - HE
Figure 1. Overview of tissue samples. Five segments from carotid endarterectomy specimen 1 (P1), one segment from carotid
endarterectomy specimen 2 (P2), and one segment from the autopsy carotid (A). Number of MALDI-MSI measurements and
adjacent histological stains
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The extract was subjected to high-resolution MS for accu-
rate mass data and MS/MS experiments for structural informa-
tion, as described in Angel et al. [24]. Ten microliters of the
extract was mixed with 190 μL of a methanol/chloroform (1/1,
v/v) mixture and infused at a rate of 240 μL/h. In a second set of
experiments, ammonium acetate was added to efficiently detect
the cholesteryl esters (CEs), 10 μL of the extract was mixed
with 180 μL of a methanol/chloroform (1/1, v/v) and 10 μL of a
10 mM ammonium acetate solution was added; the cholesteryl
esters appear as NH4
+ adducts [25].
High-resolution mass data were obtained with an LTQ
Orbitrap XLmass spectrometer with an electrospray ion source
operated in the positive ion mode using the following settings:
source voltage 4~kV and capillary temperature 300 °C. In such
experiments, the analyte molecules appear as [M + H]+ or as
[M + NH4]
+ species, whereas in MALDI imaging experiments,
they are usually cationized by residual Na+ and/or K+. Peaks
within 2 ppm of the expected m/z values were taken into
consideration for identification by MS/MS experiments.
For lipids such as the phosphatidylcholines (PC) and
sphingomyelins (SM), product ions in MS/MS spectra (for exam-
plem/z 184.1) may lie below the cut-off mass of the ion trap (27%
of precursor mass). To circumvent such discrimination effects and
to reliably identify such species,MS/MS spectra were recorded on
a triple quadrupole mass spectrometer, in our case an AB Sciex
API-3000 mass spectrometer operated in the positive ion mode,
using the following settings: source temperature 200 °C, capillary
voltage 5.5 kV, and collision energy 20 V.
Many of the ionized lipids undergo a common dissociation
reaction giving a common product ion, for example m/z 369.3
for the CE and m/z 184.1 for PC and SM. In such cases, a
precursor ion scan (i.e., a scan ofMS1 at fixedMS2) allows the
identification of the CE, PC, and SM precursor ions. Thus, both
PC and SM components are identified by setting MS2 at m/z
184.1, and then scanning MS1, whereas the CE molecules are
identified by selecting MS2 at m/z 369.1, followed by an MS1
scan. Such experiments were performed to identify all CE
components using cholesteryl heptadecanoate (CE 17:0) as
internal standard as described by Liebisch et al. [25]. The
identified peaks were matched with the internally calibrated
MSI data (Figure 3) and identification was deemed positive if
the masses agreed to within 2 ppm. Identified PCs, SMs, and
CEs are listed in supplementary information A.
Development of Data Processing Pipeline
MSI data in the form of imzML files were loaded into
MATLAB™ 2017a (Natwick, USA) unbinned, resulting in
dataset with 20,000 to 40,000 pixels per section, depending
on the imaged area, and 79,413 mass bins. Data processing
steps that were used to reduce this complex dataset and retain
the lipid spectrum exclusively are described below.
Pre-Processing
Spectral Processing Imaging Data For each image pixel, the
spectrum was smoothed using a second-order Savitzky-Golay
filter with a frame length of nine data points. After smoothing, a
post-measurement calibration was performed using DHB clus-
ter peaks as lock-mass and a linear fit, see Figure 3. In Figure 2,
a representativemean spectrum of calibratedMALDI-MSI data
is shown.
Peak-Picking We perform peak-picking to make a pre-
selection of the most important features of the data, for which
we used the base peak (BP) spectrum because of the heteroge-
neous nature of our samples. The BP spectrum shows for each
m/z value its maximum intensity measured over the entire MSI
dataset [26]. Thus, the BP spectrum allows for detection of
high-intensity lipids that are only present in a small region.
After calibration, the BP spectrum was computed for the entire
image and exported to mMass v5.5.0 [27]. We performed
peak-picking in mMass by: (1) smoothing (Savitzky-Golay
filter: window size 0.1m/z and 2 cycles), (2) baseline correction
(precision 15, relative offset 25), and (3) peak-picking (S/N
threshold 10.0, peak-picking height 80%), see Figure 3. The
filter settings used in this process were chosen heuristically: the
additional peaks that are selected with less restrictive parameter
settings are found to be removed in later processing steps. This
supports the internal consistency of the workflow we propose
here. The peak list was exported as a text file.
Imaging Data Processing
TIC-Normalization and Peak Matching The calibrated
imzML measurement and the peak list were imported into
MATLAB™ (The MathWorks, Natick, MA, USA). The data
was normalized using total-ion current (TIC) normalization;
see Figure 3. The peak list exported from mMass was used to
make a pre-selection and to that aim, the peaks of the mMass-
derived peak list were matched to the MSI data. The peak list
was generated in mMass because the mMass peak-picking
algorithm is better suited to process mass spectrometry data
than the MATLAB findpeaks algorithm. For instance, in
mMass, the noise level is calculated locally and adjusted for
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Figure 2. TypicalMALDI-MSI spectrumP1–4 calibrated,mean
spectrum, non-normalized
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every m/z value, which results in fewer false-positive peaks
compared to the findpeaks algorithm of MATLAB.
Because the data processing pipeline was developed in
MATLAB, the peaks of the mMass-derived peak list were
matched to the MSI data imported in MATLAB. Using the
findpeaks algorithm of MATLAB™, the peaks in the mean
TIC normalized spectrum of the image were detected. Subse-
quently, these peaks were matched to the peaks found in the
mMass BP spectrum with a mass tolerance of ± 0.02 m/z; this
resulted in ≈ 600 peaks. The data was subsequently binned
around these peaks, with a bin width of ± 1 data point. The
sample pitch of the TOF mass analyzer used varied with mass-
to-charge ratio, increasing from ± 0.0075 m/z at 300 m/z to ±
0.015 m/z at 1200 m/z.
Lipid Fractional Mass Filter At this point, the dataset con-
tains only the 600 most intense m/z peaks, which includes the
lipids of interest as well as background and other non-lipid
ions. To eliminate these unwanted signals, we applied several
data reduction steps, aiming to maintain only lipid-representing
m/z values. First, we applied a lipid fractional mass filter [26,
28] to remove non-lipid peaks from the dataset. Masses that
have a fractional mass outside the lipid fractional mass bound-
aries cannot be lipids and are therefore discarded; see Figure 4.
Cross-Correlation-Based Peak Selection Subsequently, we
performed peak selection based on background peaks to re-
move non-biological m/z values, similar to Fonville et al. [29].
In this method, the correlation of images with a background
reference peak was used to find matrix-related peaks and
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Figure 4. Lipid fractional mass filter. Masses outside the lipid
fractional mass boundaries cannot be lipids
Spectrum processing
CalibrationSmoothing
Data aquisition MALDI-MSI
TIC normalization
Export base peak spectrum
Mmass processing
Peak-picking
Smoothing
Baseline removal
20,000 pixels x ~600 m/z
Export peaklist
Export 
imzml
Lipid fractional 
mass filter
20,000 pixels x 400-500 m/z
Cross-correlation based 
peak selection
20,000 pixels x 200-400 m/z
Area of interest selection
7,500 pixels x 200-400 m/z
20,000 pixels x 80,000 m/z
MALDI images
6 sections per segment
Figure 3. Flowchart of MSI data processing, showing the consecutive data processing steps of the MSI data. The number of m/z
data points is reduced from 80,000 to 200–400 by peak picking, elimination of non-lipid peaks, and cross-correlation-based
background filtering. Also, the number of informative pixels is reduced from 20,000 to 7500
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embedding medium-related peaks. Only masses that correlated
negatively with this background reference mass were retained.
The reference mass was chosen upon visual inspection; for all
samples, we used 419.2 m/z as the background reference mass;
see Figure 4 step 5. Features that are important for choosing a
good reference mass are: (1) high intensity in background area,
(2) low intensity in tissue area, and (3) smooth transitions
between the two areas.
We use the background reference mass and compute the
cross-correlation using the Pearson correlation coefficient:
R2 ¼
∑

xi−x
 
yi−y
 
σxσy
We then took the 9 highest correlations to this refer-
ence mass and used these to calculate the reference to all
masses in the spectrum. We then calculated the mean
correlation of all these 10 references. If this was nega-
tive, a mass would be marked as being non-background
and retained. This step reduced the number of m/z values
to 200–400 peaks.
For sections with highly calcified regions, as were present in
P1, an extra processing step was necessary due to noise allo-
cated to the presence of these regions. This additional step is
further explained in the supplementary information B.
Area of Interest Selection After elimination of the back-
ground and non-lipid peaks, we used a K-means clustering
algorithm with N = 2 clusters to identify lipid-rich tissue areas;
see Figure 5a. Small gaps in the data were filled by first dilating
the positive structures in the image with a six-pixel circular
kernel (MATLAB™ function imdilate); see Figure 5b, and
subsequent removal with the same kernel (imerode), resulting
in a continuous region of interest for lipid analysis; see
Figure 5c.
This selection of pixels containing lipid-rich tissue was
additionally used to remove the last background peaks, by
discarding masses that were more intense in the background
pixels than in the lipid-rich tissue pixels. The combination of
data processing steps reduced the datasets to 3000–
14,000 pixels, depending on section size, and 200–400 m/z
values per measurement.
Reproducibility
With the data processing pipeline presented here, we intend to
compare lipid profiles along the length of the carotid artery
within a patient and between different patients. Therefore, we
need to estimate the variability between experiments and the
biological variation within the samples.
The coefficient of variation (CV) is a standardized mea-
sure for the variability in relation to the mean of the
population and was previously applied in MSI by Tillner
et al. [30, 31]. It is defined as the ratio of the standard
deviation of a population (σ) to the mean of a population
(μ): CV ¼ σμ 100, expressed as a percentage. CV is in-
variant to the size of the population which makes it appli-
cable to our relatively small dataset of six sections per
segment [32]. Also, CV is applicable to data with a wide
variation in mean values, which is the case for our MSI
dataset. The CV represents population variability: the lower
the CV in a set of repeated experiments, the higher is the
reproducibility of the MSI measurement.
The quantitative reproducibility of these MSI datasets
depends on the repeatability of the measurement, which
includes instrument parameters but also the stochastic ion-
ization process and efficiency of transfer into the analyzer,
the heterogeneity in the sample as prepared for imaging,
and variability between the sections within one segment.
We assessed the baseline reproducibility of the instrument
by spotting two lipid standards on top of homogenized
carotid artery tissue. Two microliters of ≈ 1000 pmol/μL
PC 17:0/17:0 and 2 μL of ≈ 1560 pmol/μL CE 17:0 were
spotted onto the homogenate. Both lipid standards were
spotted and measured six times with the instrument settings
reported in the “Materials and Experimental Methods” sec-
tion and from that data, we calculated the CV value.
After data reduction, the tissue image dataset contains 200–
400 m/z values; however, this data selection still contains
isotopes. When calculating the CV, we used the de-isotoped
m/z values (≈ 160) to avoid bias of similar isotope peaks. Every
(a) (b) (c)
Figure 5. Pixel classification. (a) Pixel selection based on K-means clustering (yellow) (N = 2). (b) Dilated pixel selection to ensure
continuity (gray). (c) Final continuous pixel selection
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segment contains six tissue sections of which we calculate the
mean intensity of the lipid-rich pixels for every m/z value.
Resulting in 6 × 160 mean intensities, making up 160 popula-
tions for which we calculate the CV. We then calculated the
mean CV value for every dataset (CV ) to allow comparison
between the different segments.
We used the histopathology images to verify if all six
sections within one segment were the same from a morpholog-
ical perspective.
Results
Reproducibility
We found that the CV of the measurement of the lipid
standard PC (17:0/17:0) is 10% for [M + H]+, 8% for
[M + Na]+, and 16% for [M + K]+. For cholesteryl esters,
we only looked at [M + Na]+, since it is the only ion that is
stable in time of flight [33], and we found a CV of 16%.
The relative intensity of the PC [M + H]+ peak is about 100
times higher than that of PC [M + K]+ and CE [M + Na]+,
which have about the same relative intensity. This means
that PC [M + H]+ is less susceptible to the influence of
noise on the signal, explaining the lower CV value.
In the imaging data, tissue structure and content was not
apparently different in the series of histologically stained sec-
tions within 1 mm segments. We thus assume that the CV
values per segment represent MALDI-MSI measurement var-
iability and not biological variability.
Figure 6 shows the CV distribution of all measured seg-
ments. P2 shows the lowestCVof 12%, also P1–1, P1–2, P1–4,
and P1–5 show relatively limited variability ranging from 14 to
25% for CV : Furthermore, P1–1, P1–2, and P1–4 show some
m/z values with a higher CV; most of these peaks could not be
identified. P1–3 and A show significantly higher CV values of
44% and 40%, respectively. Computing the total variability
across all peaks in all datasets without matching the segments,
results in a CV of 54%.
Furthermore, we expected to find that CV would be lower
when only comparing adjacent sections (30–50 μm apart),
since biological variation between these sections is relatively
minimal. Also, we hypothesized that two sections that were
measured on the same glass slide, and thus have had the exact
same sample preparation and storing conditions, would show a
lower CV . However, we did not find these conditions to
influence CV .
Relation Between Lipid Content and Plaque
Phenotype—Preliminary Observations
We hypothesize that the lipid composition of a plaque reflects
plaque phenotype, and therefore expect to find specific lipid
signatures in phenotypically different plaque structures. In our
dataset, we could examine thrombus, a key component in
ischemic events, and changes in lipid profile occurring with
development stage.
Thrombus Segment P1–4 contained thrombus; see Figure 7c,
in which monoacylglycerols (MAG), diacylglycerols (DAG),
and triacylglycerols (TAG) were abundantly present. When we
compared 300 × 300 μm regions of interest (ROIs) in tissue
segments, we found the DAGs to be more abundant in the
thrombus region of P1–4 compared to another region in the
same segment and also compared to other segments and other
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Figure 6. Coefficient of variation calculated using the mean intensity of every m/z value and comparing these values over all six
measurements per segment. The mean CV value across the m/z values is given and depicted as a horizontal line. The different
assigned lipid classes have been clustered and are color coded. (a) P1–1. (b) P1–2. (c) P1–3. (d) P1–4. (e) P1–5. (f) A. (g) P2
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tissue samples. As such, a high concentration of DAGs appears
to be thrombus-specific. In Figure 7, an example of the distri-
bution and intensity of DAG 34:2 is shown, in comparison to
the other tissue sections measured. In the supplementary infor-
mation C, a list of all peaks assigned as DAGs with distribu-
tions similar to DAG 34:2 are given.
Plaque Development Stage The autopsy sample (sample A)
contained a small fatty streak, which is an early manifestation
of atherogenic changes in the vessel wall, as can be seen on the
histological staining; Figure 8e–g. This sample was marked as
an early-stage plaque whereas the two CEA samples, P1 and
P2, were advanced atherosclerotic plaques. We compared the
differences in abundance of prominent lipid peaks between
early- and late-stage disease and found that the early lesion is
significantly enhanced in cholesteryl oleate, whereas the ad-
vanced plaques exhibit higher concentrations of cholesteryl
linoleate, see Figure 8a and c.
Discussion
In this study, we composed a framework to investigate the lipid
content of human carotid atherosclerotic plaques. Arterial tis-
sue was systematically processed for both MSI and histology,
ensuring that MSI findings could be contextualized in terms of
histopathology. Also, the data-processing pipeline presented
here can effectively and reproducibly assess the complex
MALDI-MSI dataset in a way that focuses on the lipid distri-
bution in the relevant tissue locations.
Our protocol differs from previous MALDI-MSI studies on
human atherosclerotic tissue [12, 16–18] in the followingways.
To our knowledge, this is the first study in which multiple
carotid artery plaque specimens have been measured by
MALDI-MSI. Based on this collection of carotid artery mea-
surements, we optimized our data processing protocol. We
have observed that the settings for discriminating tissue signal
from background signal by negative cross-correlation are de-
pendent on the composition of the tissue investigated, in par-
ticular the presence of calcifications. We expect that this data-
processing step may need to be adjusted when investigating
other arterial beds, and the method allows these adjustments.
Secondly, this is the first MSI study on arterial tissue that
allows measuring both differences between- and within-
specimen lipid content and determines intra and inter variations
in the tissue. Finally, we quantified the reproducibility of the
samples.
We designed the data processing pipeline to be easily ad-
justable for other MALDI-MSI research purposes. We proc-
essed the data to the standard imzML format, which is support-
ed by all MS instruments. Moreover, the processing pipeline is
generated in mMass and MATLAB, which are both software
packages in common use and easily available. The design of
our processing pipeline makes the method applicable and ad-
justable for research in other labs.
We quantified the variability of the MALDI-MSI measure-
ments by determining the coefficient of variation for the six
tissue sections measured per segment. CV varied between 12
and 44%, with an average value of 25%. Two segments, P1–3
and A, showed relatively larger variability which may be
attributed to different factors. In the case of segment P1–3,
there were large calcifications present in the sample. This
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influenced the quality and amount of tissue per glass slide,
which can be seen from the K-means pixel segmentation of
these sections shown in the supplementary information D.
These large variations in sections most likely contribute to an
elevated CV.
In the case of segment A, this tissue is biologically
different from P1 and P2, because it also contains the outer
vessel wall layers, i.e., the tunica media and tunica adven-
titia. These layers are typically not as lipid-rich as the
intimal layer. Therefore, the MALDI-MSI signal is much
lower in these areas, resulting in a lower mean intensity
value. When the mean values in the population are smaller,
the CV becomes more sensitive to relatively small chang-
es. Also, differences in sample collection may have had
an—unknown—impact. These results indicate that, in sec-
tions of lipid-rich atherosclerotic plaque, this protocol al-
lows us to achieve a quantitative accuracy of approximate-
ly 12–20% for abundant lipids, which sets a lower limit for
the detection of individual, local, or longitudinal variations
in lipid profile.
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Our analysis of three carotid plaque samples indicates that
abundance of specific subtypes of cholesteryl esters may be
related to atherosclerotic disease stage. Several studies have
associated the presence of cholesteryl oleate (m/z 673.59) with
early-stage plaques [34–39]. Our MALDI-MSI data also
showed significantly higher cholesteryl oleate intensity in the
early plaque of sample A, compared to the advanced plaques in
the CEA tissue specimens. In addition, cholesteryl linoleate
(m/z 671.57) has been shown to be more abundant in advanced
plaques, compared to early-stage plaques [40]. While our lim-
ited number of samples does not allow us to draw quantitative
conclusions, strikingly, we find cholesteryl oleate-to-linoleate
ratios that are in close agreement with previous literature [41].
In our dataset, we also observed relatively high signal of DAG
species in thrombus tissue. With the current dataset, we cannot
rule out the possibility that these DAG molecules represent
fragmented TAGs. However, relative intensities of MALDI-MSI
data of DAG molecules were different for thrombus compared to
other segments, whereas their presumed TAG precursor mole-
cules did not show this trend, indicating that we might be observ-
ing original DAG molecules, not TAG fragments. DAGs have at
least two roles in biology, first, as an intermediatemolecule for the
synthesis of TAG and phospholipids, and second, as a regulator of
protein kinaseC (PKC) isozymes, whichmodulate several cellular
processes [42]. Accumulation of DAGs has been associated with
diabetes, cancer, and cardiovascular disease [43]. PKC isoforms
have also been associated with platelet activation and
phosphatidylserine (PS) exposure [44], underlining our finding
of a high abundance of DAGs in a thrombus.
In this study, we imaged six sections per segment and
quantified the reproducibility of these sections, which is indic-
ative for the minimum fold change in intensity necessary to be
significant. In future studies, in which we plan to investigate a
larger collection of specimens, it is therefore possible to reduce
the number of sections per site that we measure. Together with
the semi-automated analysis presented here, and technological
advances such as continuous scanning modes, this makes it
feasible to perform systematic analyses of molecular lipid
composition in larger sets of atherosclerotic specimens.
In conclusion, we have developed a protocol for MALDI-
MSI measurements of lipids in human carotid plaque tissue
using a new analysis pipeline. This method can now be applied
to larger collections of carotid plaque specimens, allowing to
assess whether the carotid plaque’s lipid signature is correlated
to plaque phenotype and vulnerability. If so, this opens up new
opportunities in terms of diagnosis and patient stratification and
could enable the investigation of the effect of lipid-lowering
medication on plaque composition and rupture-risk.
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